IP
GILD icon

Investment Partners’s Gilead Sciences GILD Stock Holding History

Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$489K Sell
3,873
-795
-17% -$105K 0.15% 118
2026
Q1 		$651K Buy
4,668
+23
+0.5% +$3.22K 0.23% 92
2025
Q4 		$570K Sell
4,645
-680
-13% -$82.6K 0.2% 97
2025
Q3 		$591K Buy
5,325
+32
+0.6% +$3.64K 0.21% 93
2025
Q2 		$587K Buy
5,293
+32
+0.6% +$3.41K 0.22% 90
2025
Q1 		$590K Sell
5,261
-486
-8% -$50.1K 0.24% 86
2024
Q4 		$531K Buy
5,747
+150
+3% +$13.5K 0.22% 93
2024
Q3 		$469K Sell
5,597
-302
-5% -$23K 0.2% 95
2024
Q2 		$405K Buy
5,899
+55
+0.9% +$3.67K 0.18% 99
2024
Q1 		$428K Sell
5,844
-539
-8% -$41.4K 0.19% 98
2023
Q4 		$517K Sell
6,383
-685
-10% -$53.3K 0.25% 88
2023
Q3 		$530K Sell
7,068
-352
-5% -$27.1K 0.28% 86
2023
Q2 		$572K Buy
7,420
+51
+0.7% +$4.07K 0.3% 81
2023
Q1 		$611K Buy
7,369
+48
+0.7% +$3.98K 0.32% 81
2022
Q4 		$629K Sell
7,321
-5,339
-42% -$423K 0.33% 79
2022
Q3 		$781K Buy
+12,660
New +$798K 0.23% 100
2016
Q2 		– Sell
-2,628
Closed -$266K – 132
2016
Q1 		$266K Buy
+2,628
New +$237K 0.17% 131

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Investment Partners's GILD Position: Q2 2026 in Review

Investment Partners reduced its Gilead Sciences (GILD) stake by 17% in Q2 2026, selling an estimated $105K and leaving 3,873 shares worth $489K. The position accounts for 0.15% of the portfolio, ranked #118.

Investment Partners first reported a position in GILD in Q1 2016 and has held it in 17 quarters since. The position peaked at $781K in Q3 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Investment Partners held 3,873 shares of Gilead Sciences worth $489K as of Q2 2026.
  • Investment Partners sold 795 Gilead Sciences shares in Q2 2026, an estimated $105K.
  • Gilead Sciences made up 0.15% of Investment Partners's portfolio in Q2 2026, its #118 holding.
  • Investment Partners first reported a position in Gilead Sciences in Q1 2016 and has held it in 17 quarters since.
  • Investment Partners's Gilead Sciences position peaked at $781K in Q3 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.